Our results are in line with a recent network meta-analysis including 764 trials and 421,346 patients [25] which demonstrated that use of GLP-1RA reduces all cause and cardiovascular mortality, non-fatal myocardial infarction, non-fatal stroke, and kidney failure, with a substantial benefit on non-fatal stroke over SGLT-2 inhibitors and notable differences in the tolerability profile
PMC 10751078
Recent tests (mid-2025 onward) consistently show 99%+ purity, while earlier batches from April-May 2025 measured in the 93-95% range
Gen Comp Endocrinol 170:233252 Beckman BR, Fairgrieve W, Cooper KA, Mahnken CVW, Beamish RJ (2004) Evaluation of endocrine indices of growth in individual postsmolt coho salmon
These are not published trials
Reducing Muscle Cramps Some people experience leg cramps or general muscle tension while losing weight